🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well dabrafenib, trametinib, and spartalizu...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2020-01-29
Trial ID
NCT04310397
Treatments Being Tested
This is a single arm phase II trial focused on how dabrafenib and trametini...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2014-10-22
Trial ID
NCT02231775
Treatments Being Tested
Erdheim-Chester Diseases (ECD) is a very rare non-Langerhans cell histiocyt...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2014-11-01
Trial ID
NCT02281760
Treatments Being Tested
This clinical trial is to clarify whether treatment with a checkpoint inhib...
Status
Recruiting
Location
Herlev Universityhospital
Start Date
2018-06-06
Trial ID
NCT03563729
This is a global, multi-centre, open-label, study of GSK2118436 conducted i...
Status
Terminated
Location
GSK Investigational Site
Start Date
2014-04-08
Trial ID
NCT01978236
Treatments Being Tested
The aim of the study was to evaluate the effectiveness of combination thera...
Status
Withdrawn
Location
Saint-Petersburg State University (SPSU) N.I.Pirogov Clinic of High Medical Technologies
Start Date
2021-01-22
Trial ID
NCT04739566
Treatments Being Tested
The purpose of the study is to determine safety and tolerability of the com...
Status
Unknown
Location
West Cancer Center
Start Date
2017-06-25
Trial ID
NCT03088176
This pilot phase 2 study evaluates the effectiveness and safety of the Rech...
Status
Unknown
Location
Saint Petersburg State University Hospital
Start Date
2024-03-25
Trial ID
NCT06362694
Treatments Being Tested
This was a two-arm, randomized, double-blind Phase III study of dabrafenib ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-01-08
Trial ID
NCT01682083
Treatments Being Tested
This phase I/II trial investigates the best dose, possible benefits and/or ...
Status
Active Not Recruiting
Location
UM Sylvester Comprehensive Cancer Center at Aventura
Start Date
2021-08-19
Trial ID
NCT04557956